© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Dulcitol, also called galactitol, became known through a series of careful investigations into plant sugars in the late 1800s. Chemists stumbled upon it in fruits like European rowanberries. The rise in sugar chemistry during the industrial revolution drove serious effort into isolating and identifying sugars, with dulcitol soon revealing itself as a hexitol formed by the reduction of galactose. Knowledge of its structure and the method to derive it from galactose hydrochloride using hydrogenation set the stage for its further study. Science moved slowly back then, but by the early 20th century, scientists already understood dulcitol’s formation, crystalline nature, and sweet taste well enough to catalog it along with related polyols such as mannitol and sorbitol.
Dulcitol wears many hats as a sugar alcohol. One can find it used in lab research, sweetener exploration, and toxicology studies. While its presence in the human diet grows, its main value has often come in experimental chemistry and pharmaceutical applications. The material appears as a white or colorless crystalline solid, tasting sweet but without the familiar rapid blood sugar spike from common sugars. Its popularity in practice remains lower compared to sorbitol, partly due to production costs and availability of natural sources. It plays a central role in identifying metabolic disorders like galactosemia, a condition where the body accumulates dulcitol to dangerous levels, risking blindness due to lens protein damage.
Galactitol boasts a molecular formula of C6H14O6, giving it a hefty molecular weight of 182.17 g/mol. Crystals form as needles or prisms, dissolving readily in warm water but only modestly in cold. The melting point hovers around 188°C to 190°C, demonstrating real stability — though thermal decomposition still occurs at high temperatures. Unlike glucose, it does not ferment by yeast. Noticeably, dulcitol is optically inactive, meaning it does not rotate polarized light. This sets it apart from many similar compounds and allows for easier identification in the lab. Its low solubility in organic solvents and high solubility in water give it specific applications as an osmotic agent or a dietary sweetener for diabetics, where slow absorption limits blood sugar impact.
Commercial dulcitol products focus on purity, with specifications demanding levels of up to 98% or more, avoiding heavy metals, and keeping microbiological contamination well below thresholds accepted in pharma or food production. Most packages list galactitol as the main ingredient, with reference to batch testing. The label usually mentions purity, moisture content, melting point, and compliance with regional or international safety standards like the European Pharmacopoeia or USP. Detailed safety data sheets accompany large orders, noting the need for cool, dry storage and avoiding inhalation of dust. Companies mark dulcitol with standard codes to allow easy import and export, especially where used in manufacture or medical research.
Dulcitol does not occur in bulk from easy-to-grow crops. The reliable method depends on catalytic hydrogenation of galactose. Using a nickel catalyst and hydrogen gas, chemists reduce the aldehyde group of galactose to a hydroxyl configuration, thus creating the sugar alcohol. This process, established in early carbohydrate research, drove most commercial manufacturing through the twentieth century. Attempts to increase yield and purity continue, with tweaks to temperature, hydrogen pressure, and catalyst surface area making the operation more efficient. Fermentation methods have attracted some interest, but chemical synthesis remains dominant due to high yield and reliability.
Dulcitol’s chemical backbone welcomes a variety of modifications. Oxidation will break the molecule down into shorter polyols and carboxylic acids — useful for studying carbohydrate metabolism. Esterification of the hydroxyls provides galactitol derivatives with new properties, such as improved dispersibility in certain formulations. Under strong acid conditions, dulcitol undergoes dehydration, yielding cyclic ethers or further breakdown products. In basic media, it largely resists change, demonstrating robust chemical inertia. Scientists have also grafted dulcitol onto polymers and used it as a backbone for building new drug delivery platforms, giving it an experimental role within biomaterials research.
The world of chemistry loves synonyms. Dulcitol appears under several names: galactitol, hexahydrogalactose, and cerasin, depending on the reference. It sometimes appears as “Dulcit” in nutrition circles. In more technical documents, “D-Galactitol” or its exact chemical designation, (2R,4S,5R)-hexane-1,2,3,4,5,6-hexol, is used. Manufacturers may print all possible names on the bottle just to cover every regulatory base and search engine listing. These various names have sown confusion in literature searches, but they all point to the same unassuming sweet-tasting solid.
Even though dulcitol appears non-toxic at the usual levels encountered in the lab or food, proper handling never gets skipped. Standard guidance emphasizes avoiding dust inhalation or eye contact by using basic personal protective equipment: gloves, goggles, dust masks. Food-grade and pharma-grade dulcitol must follow strict protocols, meeting codex purity requirements and undergoing microbial screening. Transporters focus on keeping the product dry and cool, since the substance absorbs moisture and cakes. In large plants, monitoring of air quality and explosion risk from fine organic dust matters, though dulcitol’s risk sits on the low end compared to other organic powders.
Dulcitol holds a modest but unique share in industry and research. In the medical field, it serves in diagnostic assays that look for metabolic disorders, helping labs track galactose conversion in the body. In nutritional science, dulcitol sometimes appears as a specialty sweetener for diabetic diets, owing to low glycemic response. While less common in mainstream foods because of production bottlenecks, it interests manufacturers making niche health products. Scientists also use dulcitol to mimic osmotic conditions in biochemical experiments, especially in studies of plant cells and algae, as it draws water without disrupting membranes. In pharmaceuticals, dulcitol functions as a stabilizer or bulking agent, although its importance sits behind sorbitol and mannitol.
Over the past decade, R&D has tackled both fundamental and practical angles of dulcitol. Advances in hydrogenation catalysts have brought marginal cost improvements. Analytical tools, especially chromatography and spectroscopy, make tracing dulcitol in plant material or biological fluids much easier and more reliable. Biomedical researchers have grabbed onto dulcitol as a marker in genetic disease study, looking for accumulation as a signal of enzyme deficiencies. Novel applications, like using dulcitol-based hydrogels for drug delivery, move slowly from university labs into startups, with a lot of promise but plenty of technical hurdles. Sourcing cheaper galactose or engineering fermentation processes to make dulcitol more sustainably remains a holy grail for process chemists.
Large intake of dulcitol leaves its mark on the body. Research links it to osmotic stress, dehydration, and tissue damage if consumed at very high levels, mainly due to accumulation in individuals with metabolic issues like galactosemia. Rat studies show kidney swelling and some gastrointestinal disturbance at doses far beyond what anyone finds in food or pills. The sweetener’s weak absorption and slow metabolism help it avoid rapid blood sugar spikes, but excess use carries mild laxative effects, which mirrors experience with other sugar alcohols. Overall, experts rate dulcitol as having a low acute toxicity profile. Regulatory agencies have established guidelines to keep levels within safe bounds, especially in children and individuals with galactose metabolism disorders.
Efforts to bring dulcitol out of obscurity look promising as new technologies drive down cost and improve purity. Fermentation-based production, especially using engineered yeast or bacteria, could shake up the market, giving food formulators a new tool in the low-calorie sweetener game. Medical science continues to probe dulcitol as both a harmful metabolite and a potential therapeutic agent, depending on context. Its role as a bulking agent and osmotic stabilizer in pharmaceuticals seems secure. Niche uses in biomaterials and slow-release systems might expand as more researchers realize the versatility of this molecule’s multiple hydroxyl groups. The future likely belongs to those who find dual-use applications — addressing both medical and food needs — while keeping safety and sustainability at the center. As awareness increases and regulations mature, dulcitol could shed its status as a sugar chemistry footnote and claim a larger role in food and healthcare innovation.
Dulcitol, often called galactitol in labs, crops up in medical talk mostly because of how the body handles certain sugars. Folks barely talk about dulcitol at the dinner table, but scientists keep a close watch on it for a real reason: it builds up in people with a rare condition called galactosemia. I’ve run across families who only learn about dulcitol after a doctor hands them a pamphlet about inherited sugar problems. That’s when the difference between a common sweetener and a red flag for a rare disease hits home.
Galactosemia comes down to trouble breaking down galactose, a sugar found in milk and many processed foods. When someone can’t break down galactose, dulcitol starts piling up in their tissues—most alarmingly in the eyes and nerves. If you’ve ever known anyone who caught this late, you’d remember that dulcitol building up in the eye lens can cloud vision, even causing cataracts in babies. Routine newborn screening now spots this risk early, and doctors chase down dulcitol levels to help steer treatment and diet choices. Early diagnosis and cutting out galactose almost always mean fewer long-term complications. That’s why tracking dulcitol isn’t just a technical detail. It’s a signal to parents, doctors, and researchers that a child’s health future needs serious care.
It’s tempting to ask if dulcitol ever lands in foods or sweeteners, like the way sorbitol or xylitol do. But dulcitol never left the research lab or medical context. Candy-makers and food scientists gave it a look, but it never caught on as a commercial sweetener. In fact, no major health agency recommends its use in any normal diet. Most people will only hear about dulcitol through science class or because of a lab report.
Scientists dig into dulcitol not just for galactosemia, but to better understand how sugars harm the body in some diseases. In diabetes research, dulcitol stands out because excess sugar that doesn’t get processed properly can damage nerves. Building up dulcitol triggers swelling in delicate places, which links to nerve pain and vision changes. Animal studies sometimes use dulcitol to mimic these harms. Seeing how dulcitol gathers and strains tissues may open doors for future treatments—not only for patients with galactosemia but also for people whose sugar metabolism goes awry from something like poorly controlled diabetes.
Strict control of dietary galactose for people with galactosemia remains the main way to dodge dulcitol buildup. This strategy comes right out of clinical studies reviewed by groups like the National Institutes of Health. Families and patients deserve real guidance about hidden sources of galactose and solid support on sticking to life-long diets. Advances in newborn screening, more accurate diagnostic kits, and better communication among care teams change outcomes for the better. Ongoing research aims to unravel new treatment targets that could offset dulcitol’s toxic effects—bringing hope to families who’ve dealt with the tough road galactosemia often brings.
While dulcitol itself doesn’t make headlines, keeping health professionals and families aware of why it matters pays off. Every now and then, an unsung molecule like dulcitol teaches a lesson about genetics, nutrition, and the lifelong hit some rare diseases can deal. Pushing for more research and attention makes all the difference—not just in fancy labs, but in real lives.
Doctors and pharmacists recognize dulcitol (also known as galactitol) as a sugar alcohol. It sometimes pops up on the radar of people dealing with rare metabolic conditions, particularly galactosemia. While dulcitol sounds like something you’d find in candy, it builds up in the body when someone can’t properly process galactose. This isn’t a medication you’ll see on pharmacy shelves, but the effects from its accumulation matter, especially for families grappling with inherited metabolic disorders. I’ve heard families describe frustration and concern after a new diagnosis—confusion about what dulcitol actually does in the body crops up often.
Too much dulcitol leads to real problems. The human body isn’t designed to carry loads of rare sugar alcohols, especially in nerve and eye tissues. In children born with galactosemia, dulcitol can accumulate in the lens of the eye. This causes water to follow dulcitol into the lens, which clouds it, leading to cataracts. Parents of young children have described surprise at how quickly this cloudiness can appear—sometimes even before six months of age. If not detected, it can steal a child’s vision. Early newborn screening for galactosemia allows doctors to act fast and protect kids from that risk.
Some research has linked dulcitol buildup to nerve issues, too. Peripheral neuropathy—numbness, tingling, or pain in the hands and feet—shows up more often in people with hereditary problems processing galactose. Scientists believe dulcitol sitting in nerve cells changes how those nerves talk to muscles and the brain. That can mean weak grip strength or problems with balance. These nerve effects can bring frustration to daily movement and make simple activities more complicated.
In animal studies, higher dulcitol levels tie back to problems in organs like the kidneys and the brain. For people, major symptoms still connect mostly to eyes and nerves. Still, lingering dulcitol could stress other organs and disrupt cell function. Fatigue and developmental delays may also show up over time in untreated galactosemia.
Dulcitol itself doesn’t come with the stomach symptoms that people get from common sugar substitutes like sorbitol or xylitol. It’s not added to foods as a sweetener due to its link with rare disease and its tendency to build up for the wrong reasons. Its presence signals bigger medical issues rather than causing digestive discomfort for most folks.
For families navigating galactosemia, the path forward relies on strict diets. Removing galactose from food, especially cutting out milk and certain dairy products, prevents dulcitol from accumulating to dangerous levels. Many parents describe feeling overwhelmed at first, but dieticians and rare disease nurses provide practical tips. Finger-prick blood tests monitor levels of galactose and related compounds, while regular eye exams keep watch for cataracts.
Researchers continue exploring therapies that might break down or block dulcitol’s buildup. While no medicine exists yet to clear dulcitol out directly, gene therapy trials and enzyme replacements look promising. For now, early detection and everyday management carry the load. The focus remains on lowering galactose in the diet, tracking physical and cognitive development, and protecting vision and nerve health with regular screenings. These steps offer the best shot at reducing dulcitol’s side effects for the foreseeable future.
Dulcitol came to my attention a few years ago after a friend's son was prescribed it for galactosemia. Dulcitol, which is also known as galactitol, is a type of sugar alcohol found in some plants and fruits. Pharmacists sometimes encounter it in specialized care, not your everyday medication aisle. Doctors use it in rare cases for certain metabolic disorders or as a sugar substitute for people who can’t break down regular sugars.
Doctors usually tailor the dose and method to the medical condition at hand. Nobody should just grab the product and self-dose. Every experienced pharmacist will say this: trust what your doctor recommends and pay careful attention to the prescribed dose. Skipping this step can lead to health risks.
Dulcitol works differently from familiar sugars. In therapeutic settings, it typically comes in measured amounts, either as a powder to dissolve or as part of a compounded preparation. Patients mix the powder with liquids, such as water or juice, just as the pharmacist tells them. Bringing the solution close to room temperature can help it dissolve smoothly, and stirring helps avoid gritty residue.
Dulcitol’s presence in specialized therapy means regular communication with healthcare professionals becomes even more important. Risks stack up quickly without medical supervision. I’ve seen parents worry about adjusting a child’s intake at home, which always leads to extra calls to the specialist. Clear instructions should cover dose, timing, and what side effects to watch for. Nausea, bloating, and stomach cramps sometimes pop up, especially if the body isn’t used to sugar alcohols.
Some folks with certain kidney conditions or metabolic issues probably should not take dulcitol at all. Before starting any regimen, lab tests and a full health check protect against unwanted surprises.
Research backs up the need for caution. According to studies from the National Institutes of Health, dulcitol builds up in tissue for some people with galactosemia. In these rare cases, long-term exposure can cause complications, especially in nerves and eyes. Monitoring through specialist clinics becomes essential.
For patients who need dulcitol, taking it exactly as prescribed brings the best chance for symptom control without complications. Trying to swap out sugar in drinks with dulcitol from a web retailer only adds risk. Over-the-counter sources might not match pharmaceutical standards. Purity matters—nobody wants contaminants sneaking into a daily supplement.
People who require this compound push researchers to search for better sugar substitutes and safer treatment options. Most wish for something easier to handle at home and with fewer side effects. Until that day, careful management and a good partnership between patient, doctor, and pharmacist remain the best approach. Sharing knowledge in support groups and keeping up with annual checkups make life with rare metabolic disorders less daunting, especially for families already stretched thin by ongoing care.
Dulcitol, often listed on food labels as galactitol, pops up in a lot of places. Food manufacturers use it as a sugar substitute. The pharmaceutical world leans on it, too, since it works as a mild diuretic and laxative. People hear “sugar alcohol” and think it’s harmless, but not all sugar alcohols work the same in our bodies.
Long-term safety matters. People don’t just want to avoid a stomachache after eating a snack. They want to know if something builds up in organs or messes with health over years. Most folks who eat packaged foods, take daily meds, or have diabetes care about these details. For some, dulcitol is a daily thing.
Decades ago, researchers started digging into galactitol’s effects after noticing it builds up in people with galactosemia – a rare genetic disorder. Too much dulcitol in their brains and eyes leads to all kinds of trouble, from cataracts to nerve damage. People without the disorder process galactitol differently, but high intake for everyone hasn’t been studied much.
Animal studies show long-term, high-dose dulcitol can mess with kidney and nervous system function. In rats, cataracts showed up after a steady diet rich in galactitol. Human studies run thinner. The FDA puts dulcitol on the “generally recognized as safe” list for normal food use, but those guidelines assume only small amounts get eaten here and there.
As someone who used to eat a lot of “sugar-free” and “diet” snacks, I always paid attention to side effects. After a while, I’d get bad bloating and, sometimes, loose stool — a common side effect, even at moderate doses. Friends who tried sugar-free gum or chocolate for weeks had the same complaints. People with stomach conditions or IBS struggle even more.
After reading up, I realized the body doesn’t break down dulcitol completely. It ferments in the gut, just like sorbitol, another sugar alcohol. Gas, cramping, and sometimes diarrhea catch up, especially if you eat more than 10 grams in a sitting. Unlike erythritol or xylitol, dulcitol’s sweetening effect is pretty weak, so manufacturers use a lot more to get the same level of sweetness, increasing risk for side effects.
Long-term use brings up questions beyond the stomach. For people without galactosemia, moderate use looks okay, but high, chronic intake hasn’t been studied in big human trials. People with diabetes may end up using more dulcitol by accident, not realizing the bowel effects or other possible risks.
A bigger worry: dulcitol may contribute to cataract development, at least based on animal research. Cataracts grow slowly and quietly, so decades of use could matter. Most regulatory bodies ask companies to label sugar alcohols, so consumers notice them—but nobody stands over your shopping cart, adding up dulcitol grams.
Small tweaks help. Read the ingredient list. If dulcitol sits high up, treat the product like an occasional treat. If you live with digestive issues, take it easy and see how your gut reacts. If you already have galactosemia in the family, skip dulcitol.
Looking ahead, more public research could close knowledge gaps. Companies could invest in finding safe upper limits for long-term use. Doctors and dietitians already help people track these hidden sugars, but they could work with patients on reflecting symptom patterns, especially if they use daily meds or meal replacements sweetened with dulcitol.
Safe use means knowing how your body reacts — and not letting hidden ingredients fly under the radar.
Dulcitol, often called galactitol, comes from the breakdown of galactose, a milk sugar. Some doctors see it show up in medical discussions linked to rare genetic disorders like galactosemia. Most folks don’t bump into dulcitol except when diving deep into discussions about sugar metabolism problems. It’s far from common in medicines or supplements.
Questions pop up fast when someone talks about taking any substance during pregnancy or while breastfeeding. Every mom wants the best for her baby, and every parent worries whether something could sneak past the usual safety checks. I remember watching new mothers in a clinic sift through ingredient lists and cross-check every detail online or with their doctor. Anxiety often rises just from facing unfamiliar names.
Dulcitol isn’t on the list of approved sweeteners or drugs for pregnant women, and few studies track what it does inside a pregnant body. Most health professionals prefer to stick with options that carry a clear safety record. There’s no public record of safety trials focused on dulcitol for this group. In the big world of medicine, if we can’t find positive proof, most experts say to avoid it. The risks may run low, but no one wants to gamble with an unborn child’s health.
Researchers link dulcitol buildup to a rare genetic problem called galactosemia. Babies with this condition can get seriously sick, and the body’s inability to process galactose causes dulcitol accumulation, which harms organs such as the eyes and brain. In people without galactosemia, dulcitol doesn’t play a part in daily nutrition, and doctors don’t recommend it for any practical use in food or medicine.
Most guidelines follow a rule: If something hasn’t been studied closely in pregnant or breastfeeding women, it’s better to skip it. The Food and Drug Administration and similar groups haven’t approved dulcitol as an ingredient in food or supplements. Groups like the American Academy of Pediatrics recommend caution with all untested substances during pregnancy and nursing.
Breastfeeding carries its own set of worries. Anything a mother eats or drinks may reach her baby through breastmilk. Some chemicals and sugars cross more easily than others. Without solid studies on dulcitol’s effects on infants, there’s no reason to take that chance.
Clear information from trusted sources helps new moms make healthy choices. Doctors, pharmacists, and registered dietitians play a big part in sorting facts from rumors or risky trends. Whenever someone presents something like dulcitol as a supplement or a “natural” option for pregnancy or nursing, it sets off alarm bells. Trained health professionals won’t recommend anything without a good body of evidence.
The safest bet: Stay with what’s proven, and ask questions if something unfamiliar pops up. In my own family or among friends, leaning on well-known options gives peace of mind. If confusion lingers, checking with a doctor before using anything new makes sense. Only proper scientific research can answer these questions, and until that arrives, dulcitol stays off the recommended list for women who are pregnant or breastfeeding.
| Names | |
| Preferred IUPAC name | hexane-1,2,3,4,5,6-hexol |
| Other names |
Galactitol Galactit |
| Pronunciation | /ˈdʌl.sɪ.tɒl/ |
| Identifiers | |
| CAS Number | 608-66-2 |
| Beilstein Reference | 1986700 |
| ChEBI | CHEBI:16601 |
| ChEMBL | CHEBI:17176 |
| ChemSpider | 5736 |
| DrugBank | DB01643 |
| ECHA InfoCard | 100.031.441 |
| EC Number | 3.1.3.18 |
| Gmelin Reference | 6077 |
| KEGG | C00794 |
| MeSH | C0060966 |
| PubChem CID | 12197 |
| RTECS number | LU5950000 |
| UNII | 1U1QTN40SY |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C6H14O6 |
| Molar mass | 182.17 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.52 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -3.06 |
| Vapor pressure | Vapor pressure: <0.0001 mm Hg (25°C) |
| Acidity (pKa) | 13.15 |
| Basicity (pKb) | 1.58 |
| Magnetic susceptibility (χ) | -7.1e-6 |
| Refractive index (nD) | 1.455 |
| Viscosity | Solid |
| Dipole moment | 2.44 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 409.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -1587.5 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3584.7 kJ/mol |
| Pharmacology | |
| ATC code | A06AD15 |
| Hazards | |
| Main hazards | May cause irritation to the respiratory tract, eyes, and skin. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | eye irritation, health hazard |
| Signal word | Warning |
| Hazard statements | Hazard statements: Not a hazardous substance or mixture according to the Globally Harmonized System (GHS). |
| Precautionary statements | Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. |
| NFPA 704 (fire diamond) | 1-0-0 |
| Autoignition temperature | 380 °C |
| Explosive limits | Explosive limits not found. |
| Lethal dose or concentration | LD50 (oral, rat): 16,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): 22 gm/kg (oral, rat) |
| NIOSH | GN8225000 |
| PEL (Permissible) | 10 mg/m3 |
| REL (Recommended) | 20 g |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Sorbitol Galactose Mannitol |
